Skip to main content

Shattuck Labs, Inc.

STTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001680367

In the last 90 days, Shattuck Labs, Inc. insiders filed 0 open-market purchases and 1 sale; 100 institutions reported holding it in 13F filings for Q2 2026, worth $581.3M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Shattuck Labs, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of STTK: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders7263−9
Shares21.4M20.6M−774.1K (−3.6%)
Value$87.0M$55.7M−$31.3M (−36.0%)

New holders (7)

Institutions that held Shattuck Labs, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to STTK in Q3 2022
InstitutionSharesValue% of portfolio
Keybank National Association115,347$311.0K0.00%
Dimensional Fund Advisors LP50,434$136.0K0.00%
Curi Capital50,000$135.0K0.02%
Balyasny Asset Management LLC12,858$35.0K0.00%
Federated Hermes, Inc.385$1.00K0.00%
Point72 Hong Kong Ltd386$1.00K0.00%
China Universal Asset Management Co., Ltd.397$1.00K0.00%

Sold out (16)

Institutions that held Shattuck Labs, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.